Diabetologia 65:19251966
Discover the research Description PT-141, also known as Bremelanotide, is a synthetic cyclic heptapeptide analog of alpha-melanocyte-stimulating hormone (alpha-MSH)
This peptide-pathway genetic test examines 14 metabolic pathways and 150+ genetic insightsincluding variants in GLP1R (rs6923761), GIPR (rs1800437), FTO (rs9939609), and MC4R (rs17782313)to reveal how your body may respond to GLP-1 therapy and which compounds align best with your genetic predispositions
Expected benefits develop over 3 to 6 months and include improved recovery from exercise, enhanced sleep quality, increased mobilization of stubborn fat, and preservation or increase of lean muscle mass
MK-677 (ibutamoren) is a non-peptide spirojo-piperidine compound, which allows for oral bioavailability (peptides are degraded in the digestive tract)
Conversely, small-molecule agonists like Acetyl GLP-1 MAX bind preferentially to an allosteric site within the TMD